AbbVie/Genmab’s Epkinly granted FDA accelerated approval to treat follicular lymphoma
Approximately 15,000 people develop the form of non-Hodgkin lymphoma every year in the US
Read More
Jun 27, 2024 | News, Regulatory
Approximately 15,000 people develop the form of non-Hodgkin lymphoma every year in the US
Read MoreJun 27, 2024 | News, Regulatory
More than 390 million people worldwide are living with COPD and about half of patients experience almost daily symptoms
Read MoreApproximately 40% of people living with type 2 diabetes will develop CKD
Read MoreThe rare immunoglobulin-mediated autoimmune disease affects four in every 100,000 people annually
Read MoreAntimicrobial resistance has been declared by WHO as one of the top ten global public health threats
Read MoreMore than 614,000 new cases of the disease are diagnosed globally every year
Read MoreThe inherited bleeding disorder accounts for up to 85% of the 1,125,000 global haemophilia cases
Read MorePanIN lesions can lead to invasive ductal adenocarcinoma, which affects nearly half a million people globally
Read MoreHereditary ATTR and wild-type ATTR are responsible for an estimated 350,000 cases globally
Read MoreJun 25, 2024 | News, Regulatory
The injection has the same twice-yearly schedule as the previously approved intravenous infusion
Read MoreJun 25, 2024 | News, Regulatory
The regulator’s decision was supported by evidence demonstrating Tofidence’s similarity to the reference product
Read MoreJun 25, 2024 | News, Regulatory
Approximately 24,000 US patients are currently being treated for chronic inflammatory demyelinating polyneuropathy
Read MoreIntegrated Care Specialist - North & West Yorkshire
Territory Sales Manager - Yorkshire/North East
Territory Sales Manager - North London & East Anglia
Key Account Manager - Urology - East Anglia, Beds & Bucks
Territory Sales Manager - Ostomy Care - S Central/SW England